Mahamaya Lifesciences IPO – Key Details and Investment Highlights
The Mahamaya Lifesciences IPO will open for subscription on November 11, 2025, and close on November 13, 2025. It is a Book Built Issue, with the company aiming to raise approximately ₹70.44 crores through this public offering. The IPO comprises a fresh issue worth ₹64.28 crores and an offer for sale (OFS) of up to 5,40,800 equity shares with a face value of ₹10 each.
The price band for the Mahamaya Lifesciences IPO is fixed between ₹108 and ₹114 per share. The issue allocation includes 50% for Qualified Institutional Buyers (QIBs), 15% for Non-Institutional Investors (HNIs), and 35% for Retail Investors. The IPO allotment date is scheduled for November 14, 2025, and the shares are expected to be listed on the BSE on November 18, 2025.
In terms of financial performance, Mahamaya Lifesciences reported a revenue of ₹267.17 crores in FY 2025, compared to ₹162.83 crores in FY 2024. The company’s net profit also grew significantly to ₹12.94 crores in FY 2025, up from ₹5.22 crores in FY 2024.
With consistent revenue growth and improved profitability, Mahamaya Lifesciences demonstrates strong fundamentals and promising future potential. Based on its financial trajectory, long-term investors may find this IPO a valuable addition to their portfolio.
Mahamaya Lifesciences IPO Objectives:
The net proceeds from the IPO are proposed to be utilized for the following purposes:
| Purpose | Amount (₹ in Crores) |
|---|---|
| Purchase of equipment for the existing formulation plant | ₹3.75 |
| Funding capital expenditure for setting up a new technical manufacturing plant | ₹29.42 |
| Construction of a warehouse building and purchase of machinery | ₹2.53 |
| Funding working capital requirements of the company | ₹18.00 |
| General corporate purposes | — |
Mahamaya Lifesciences IPO Review (Apply or Not)
- May Apply
Mahamaya Lifesciences IPO Date & Price Band Details:
| IPO Open Date | November 11, 2025 |
| IPO Close Date | November 13, 2025 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹108 to ₹114 Per Share |
| Issue Size | Approx ₹70.44 Crores |
| Fresh Issue | Approx ₹64.28 Crores |
| Offer for Sale: | Approx 5,40,000 Equity Shares |
| Issue Type | Book Built Issue |
| IPO Listing | BSE SME |
| DRHP Draft Prospectus | Link |
| RHP Draft Prospectus | Link |
Mahamaya Lifesciences IPO Lot Size:
The minimum market lot for the Mahamaya Lifesciences IPO is 2,400 shares, requiring a minimum application amount of ₹2,73,600 for retail investors.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 2,400 | ₹2,73,600 |
| Retail Maximum | 2 | 2,400 | ₹2,73,600 |
| S-HNI Minimum | 3 | 3,600 | ₹4,10,400 |
| S-HNI Maximum | 7 | 8,400 | ₹9,57,600 |
| B-HNI Minimum | 8 | 9,600 | ₹10,94,400 |
Mahamaya Lifesciences IPO Allotment & Listing Date (Details)
The Mahamaya Lifesciences IPO will open on November 11, 2025, and close on November 13, 2025. The IPO allotment is expected to be finalized on November 14, 2025, while the shares are scheduled to be listed on the BSE on November 18, 2025.
| IPO Open Date: | November 11, 2025 |
| IPO Close Date: | November 13, 2025 |
| Basis of Allotment: | November 14, 2025 |
| Refunds: | November 17, 2025 |
| Credit to Demat Account: | November 17, 2025 |
| IPO Listing Date: | November 18, 2025 |
| IPO Bidding Cut-off Time: | November 13, 2025 – 5 PM |
Mahamaya Lifesciences IPO GMP Today:
- Update Soon
Promoters of Mahamaya Lifesciences IPO
The promoters of Mahamaya Lifesciences Limited are Mr. Krishnamurthy Ganesan, Mr. Prashant Krishnamurthy, and Mrs. Lalitha Krishnamurthy.
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 1,77,66,200 | 77.27% |
| Promoter Holding Post Issue | 2,34,05,000 | 56.35% |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Nova Agritech Limited | 3.05 | 16.93 | 12.47% | 23.76 | 296.60 Cr. |
| Bhagiradha Chemicals & Industries Limited | 1.14 | 247.63 | 2.03% | 52.61 | 449.75 Cr. |
Mahamaya Lifesciences IPO– Company Financial Performance
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2022 | ₹90.16 | ₹86.43 | ₹2.72 | ₹55.71 |
| 2023 | ₹137.40 | ₹132.30 | ₹3.75 | ₹77.88 |
| 2024 | ₹162.83 | ₹155.71 | ₹5.22 | ₹112.07 |
| 2025 | ₹267.17 | ₹249.81 | ₹12.94 | ₹188.35 |
| June 2025 | ₹84.04 | ₹78.35 | ₹4.10 | ₹218.87 |
Mahamaya Lifesciences IPO Registrar
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: mahamaya.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/
Mahamaya Lifesciences IPO Lead Managers aka Merchant Bankers
- Oneview Corporate Advisors Pvt.Ltd.
Mahamaya Lifesciences IPO Company Address
Mahamaya Lifesciences Ltd.
Unit No: DPT – 033, Ground Floor,
Plot No: 79 – 80, DLF Prime Tower,
Block, Okhla, Phase – 1
Delhi, New Delhi, 110020
Phone: +91-1146561474
Email: cs@mahamayalifesciences.com
Website: https://www.mahamayalifesciences.com/
Mahamaya Lifesciences IPO FAQs
Q1. What is the Mahamaya Lifesciences IPO date?
The Mahamaya Lifesciences IPO opens on November 11, 2025, and closes on November 13, 2025.
Q2. What is the price band of the Mahamaya Lifesciences IPO?
The price band for the IPO is fixed between ₹108 and ₹114 per share.
Q3. What is the lot size of the Mahamaya Lifesciences IPO?
Investors can apply for a minimum of 2,400 shares, requiring an application amount of ₹2,73,600.
Q4. How much is Mahamaya Lifesciences IPO expected to raise?
The company aims to raise approximately ₹70.44 crores through this IPO.
Q5. What is the allotment and listing date of the Mahamaya Lifesciences IPO?
The IPO allotment will be finalized on November 14, 2025, and the listing is expected on the BSE on November 18, 2025.
Q6. Who are the promoters of Mahamaya Lifesciences Limited?
The promoters of the company are Mr. Krishnamurthy Ganesan, Mr. Prashant Krishnamurthy, and Mrs. Lalitha Krishnamurthy.
Q7. What will the IPO proceeds be used for?
The proceeds will be utilized for purchasing equipment, setting up a new technical manufacturing plant, constructing a warehouse, meeting working capital needs, and general corporate purposes.
Q8. On which exchange will the Mahamaya Lifesciences IPO be listed?
The shares will be listed on the BSE.
